A., Tarafdar, S., Agarwal, S., Tarafdar, A
Nrf2 protects against COPD through transcriptional activation of antioxidants and antiproteases in alveolar macrophages
The review documented risks including cardiovascular strain, insulin resistance, and dyslipidaemia in uncontrolled use settings (PMID 41880199
Thermo Fisher Scientific)
The researchers were looking for studies of at least 12 weeks duration that were done on healthy subjects with no other supplement ingredients included and no use of drugs
A study published as far back as 2013 linked melanotan II use to changes in mole morphology and atypical skin lesions, raising red flags about long-term safety and the risk of melanoma